Your browser doesn't support javascript.
loading
Test-retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study.
Curtis, Randall; Wu, Joanne; Iorio, Alfonso; Frick, Neil; Nichol, Michael; Noone, Declan; O'Mahony, Brian; Page, David; Stonebraker, Jeffrey; Kucher, Alexandra; Clearfield, Elizabeth; Skinner, Mark W; Germini, Federico.
Afiliação
  • Curtis R; Factor VIII Computing, Berkeley, USA.
  • Wu J; Sol Price School of Public Policy, University of Southern California, Los Angeles, USA.
  • Iorio A; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Frick N; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
  • Nichol M; National Hemophilia Foundation, New York, USA.
  • Noone D; Sol Price School of Public Policy, University of Southern California, Los Angeles, USA.
  • O'Mahony B; Irish Haemophilia Society, Dublin, Ireland.
  • Page D; Irish Haemophilia Society, Dublin, Ireland.
  • Stonebraker J; Trinity College Dublin, Dublin, Ireland.
  • Kucher A; Canadian Hemophilia Society, Montreal, Canada.
  • Clearfield E; Poole College of Management, North Carolina State University, Raleigh, USA.
  • Skinner MW; Patient Outcomes Research Group Ltd, Washington, District of Columbia, USA.
  • Germini F; Institute for Policy Development Ltd, Washington, District of Columbia, USA.
Haemophilia ; 30(3): 702-708, 2024 May.
Article em En | MEDLINE | ID: mdl-38439137
ABSTRACT

INTRODUCTION:

The Patient Reported Outcomes, Burdens, and Experiences (PROBE) questionnaire is a patient-reported outcome tool that assesses quality of life and disease burden in people with haemophilia (PWH).

AIM:

To assesses the test-retest reliability of PROBE when completed using the mobile phone application.

METHODS:

We recruited PWH, including carriers, and individuals with no bleeding disorders who attended haemophilia-related workshops or via social media. Participants completed PROBE three times (twice on the app T1 and T2, and once on the web, T3). Test-retest reliability was analysed for T1 versus T2 (app to app, time period one) and T2 versus T3 (app to web, time period two).

RESULTS:

We enrolled 48 participants (median age = 56 [range 27-78] years). Eighteen participants (37.5%) were PWH and seven (14.6%) were carriers. On general health domain questions, we found almost perfect agreement, except for a question on the frequency of use of pain medication in the last 12 months [Kappa coefficient (κ) .72 and .37 for time period one and two, respectively] and any use of pain medications (κ .75) for time period two. For haemophilia-related questions, we found substantial to perfect agreement, except for the questions on the number of joint bleeds in the previous 6 months for time period one (κ .49) and the number of bleeds in the previous two weeks for time period two (κ .34).

CONCLUSIONS:

The results demonstrate the reliability of the PROBE app. The app can be used interchangeably with the paper and web platforms for PROBE administration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aplicativos Móveis / Medidas de Resultados Relatados pelo Paciente / Hemofilia A Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haemophilia Assunto da revista: HEMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aplicativos Móveis / Medidas de Resultados Relatados pelo Paciente / Hemofilia A Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haemophilia Assunto da revista: HEMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos